Levistolide�A synergistically enhances doxorubicin‑induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levistolide�A synergistically enhances doxorubicin‑induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway

Published:2018-11-27 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Ding Yuanyuan¹,Niu Weibo²,Zhang Tao³,Wang Jue³,Cao Jiao³,Chen He¹,Wang Ruiqi¹,An Hongli¹

Affiliation:

1. Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China

2. Department of General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China

3. Institute of Materia Medica, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levistilide A Exerts a Neuroprotective Effect by Suppressing Glucose Metabolism Reprogramming and Preventing Microglia Polarization Shift: Implications for Parkinson’s Disease;Molecules;2024-02-19

2. Suppression of VEGF and inflammatory cytokines, modulation of Annexin A1 and organ functions by galloylquinic acids in breast cancer model;Scientific Reports;2023-07-28

3. Levistolide A and periplogenin inhibit the growth of gastric cancer cells in vitro and in vivo;Exploration of Drug Science;2023-03-30

4. Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin;Drug Delivery;2022-05-30

5. Detection of apoptotic and necrotic cell death using holographic microscopy;Label-free Biomedical Imaging and Sensing (LBIS) 2022;2022-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3